Difluprednate Emulsion
Product Images NDC 69315-329

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Difluprednate (NDC 69315-329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

This text is a detailed description of a pharmaceutical product, specifically Difluprednate Ophthalmic Emulsion 0.05%. The manufacturer is Capiin Steries Limited in India, and it is distributed by Leading Pharma, LLC in the USA. The product is intended for eye use only and is sterile. The emulsion contains active and inactive ingredients, with the preservative being sorbic acid 0.1%. The text also provides information on dosage, storage instructions, and prescription details. It is important to read the package insert for full prescribing information. The product is available in a 5mL bottle.*

FDA Label Image

Chemicalstructure (Chemstruc)

FDA Label Image

Containerlabel (Containerlabel)

This is a description of a prescription-only medication called Difluprednate Ophthalmic Emulsion for use in the eyes. It is a sterile solution provided in a 5mL container. Each mL of this emulsion contains 0.5 mg of difluprednate. The usual dosage instructions can be found in the package insert. It is important to store the medication at a temperature between 20°C to 25°C (68°F to 77°F) and to protect it from light. The manufacturer is Caplin Steriles Limited in India, and it is distributed by Leading Pharma, LLC in the USA. Additionally, the product has a unique code for identification purposes.*

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

This text discusses the percentage of subjects who were pain-free on Day 3 and Day 15 after using Difluprednate ophthalmic emulsion 0.05% four times a day. A comparison is made between the treatment group (n=107) and the placebo group (n=20), showing a statistically significant difference (P<0.05).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.